750 related articles for article (PubMed ID: 34115801)
1. COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system.
Coppock D; Baram M; Chang AM; Henwood P; Kubey A; Summer R; Zurlo J; Li M; Hess B
PLoS One; 2021; 16(6):e0252591. PubMed ID: 34115801
[TBL] [Abstract][Full Text] [Related]
2. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
[TBL] [Abstract][Full Text] [Related]
3. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review.
Cantini F; Goletti D; Petrone L; Najafi Fard S; Niccoli L; Foti R
Drugs; 2020 Dec; 80(18):1929-1946. PubMed ID: 33068263
[TBL] [Abstract][Full Text] [Related]
4. Retrospective evaluation of seven different treatment protocols in hospitalized COVID-19 patients.
Demir Önder K; Seremet Keskin A; Berk H; Seyman D; Öztoprak N
Turk J Med Sci; 2021 Dec; 51(6):2835-2849. PubMed ID: 34418000
[TBL] [Abstract][Full Text] [Related]
5. [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.].
Cruciani F; Amato L; De Crescenzo F; Mitrova Z; Saulle R; Vecchi S; Davoli M
Recenti Prog Med; 2021 Mar; 112(3):195-206. PubMed ID: 33687358
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?
Shafiekhani M; Shahabinezhad F; Niknam T; Tara SA; Haem E; Mardani P; Zare Z; Jafarian S; Mirzad Jahromi K; Arabsheybani S; Moeini YS; Alavi J; Jalali SS; Salimi M; Shahriarirad R; Malekhosseini SA
Virol J; 2021 Nov; 18(1):228. PubMed ID: 34809657
[TBL] [Abstract][Full Text] [Related]
7. Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study.
Mehta HB; An H; Andersen KM; Mansour O; Madhira V; Rashidi ES; Bates B; Setoguchi S; Joseph C; Kocis PT; Moffitt R; Bennett TD; Chute CG; Garibaldi BT; Alexander GC;
Ann Intern Med; 2021 Oct; 174(10):1395-1403. PubMed ID: 34399060
[TBL] [Abstract][Full Text] [Related]
8. Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
Rivera DR; Peters S; Panagiotou OA; Shah DP; Kuderer NM; Hsu CY; Rubinstein SM; Lee BJ; Choueiri TK; de Lima Lopes G; Grivas P; Painter CA; Rini BI; Thompson MA; Arcobello J; Bakouny Z; Doroshow DB; Egan PC; Farmakiotis D; Fecher LA; Friese CR; Galsky MD; Goel S; Gupta S; Halfdanarson TR; Halmos B; Hawley JE; Khaki AR; Lemmon CA; Mishra S; Olszewski AJ; Pennell NA; Puc MM; Revankar SG; Schapira L; Schmidt A; Schwartz GK; Shah SA; Wu JT; Xie Z; Yeh AC; Zhu H; Shyr Y; Lyman GH; Warner JL;
Cancer Discov; 2020 Oct; 10(10):1514-1527. PubMed ID: 32699031
[TBL] [Abstract][Full Text] [Related]
9. Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study.
Gressens SB; Esnault V; De Castro N; Sellier P; Sene D; Chantelot L; Hervier B; Delaugerre C; Chevret S; Molina JM;
PLoS One; 2022; 17(2):e0262564. PubMed ID: 35176057
[TBL] [Abstract][Full Text] [Related]
10. Management and outcomes of patients hospitalized with severe COVID-19 at a tertiary care center in midwestern United States.
Gupta S; Kaushik A; Gupta J
Monaldi Arch Chest Dis; 2020 Oct; 90(4):. PubMed ID: 33059413
[TBL] [Abstract][Full Text] [Related]
11. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
Pandolfi L; Fossali T; Frangipane V; Bozzini S; Morosini M; D'Amato M; Lettieri S; Urtis M; Di Toro A; Saracino L; Percivalle E; Tomaselli S; Cavagna L; Cova E; Mojoli F; Bergomi P; Ottolina D; Lilleri D; Corsico AG; Arbustini E; Colombo R; Meloni F
BMC Pulm Med; 2020 Nov; 20(1):301. PubMed ID: 33198751
[TBL] [Abstract][Full Text] [Related]
12. Psychopharmacology of COVID-19.
Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial.
Barratt-Due A; Olsen IC; Nezvalova-Henriksen K; Kåsine T; Lund-Johansen F; Hoel H; Holten AR; Tveita A; Mathiessen A; Haugli M; Eiken R; Kildal AB; Berg Å; Johannessen A; Heggelund L; Dahl TB; Skåra KH; Mielnik P; Le LAK; Thoresen L; Ernst G; Hoff DAL; Skudal H; Kittang BR; Olsen RB; Tholin B; Ystrøm CM; Skei NV; Tran T; Dudman S; Andersen JT; Hannula R; Dalgard O; Finbråten AK; Tonby K; Blomberg B; Aballi S; Fladeby C; Steffensen A; Müller F; Dyrhol-Riise AM; Trøseid M; Aukrust P;
Ann Intern Med; 2021 Sep; 174(9):1261-1269. PubMed ID: 34251903
[TBL] [Abstract][Full Text] [Related]
14. Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a propensity score matched analysis.
Veronese N; Di Gennaro F; Frallonardo L; Ciriminna S; Papagni R; Carruba L; Agnello D; De Iaco G; De Gennaro N; Di Franco G; Naro L; Brindicci G; Rizzo A; Bavaro DF; Garlisi MC; Santoro CR; Signorile F; Balena F; Mansueto P; Milano E; Giannitrapani L; Fiordelisi D; Mariani MF; Procopio A; Lattanzio R; Licata A; Vernuccio L; Amodeo S; Guido G; Segala FV; Barbagallo M; Saracino A
Sci Rep; 2024 Apr; 14(1):9303. PubMed ID: 38654033
[TBL] [Abstract][Full Text] [Related]
15. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
; Pan H; Peto R; Henao-Restrepo AM; Preziosi MP; Sathiyamoorthy V; Abdool Karim Q; Alejandria MM; Hernández García C; Kieny MP; Malekzadeh R; Murthy S; Reddy KS; Roses Periago M; Abi Hanna P; Ader F; Al-Bader AM; Alhasawi A; Allum E; Alotaibi A; Alvarez-Moreno CA; Appadoo S; Asiri A; Aukrust P; Barratt-Due A; Bellani S; Branca M; Cappel-Porter HBC; Cerrato N; Chow TS; Como N; Eustace J; García PJ; Godbole S; Gotuzzo E; Griskevicius L; Hamra R; Hassan M; Hassany M; Hutton D; Irmansyah I; Jancoriene L; Kirwan J; Kumar S; Lennon P; Lopardo G; Lydon P; Magrini N; Maguire T; Manevska S; Manuel O; McGinty S; Medina MT; Mesa Rubio ML; Miranda-Montoya MC; Nel J; Nunes EP; Perola M; Portolés A; Rasmin MR; Raza A; Rees H; Reges PPS; Rogers CA; Salami K; Salvadori MI; Sinani N; Sterne JAC; Stevanovikj M; Tacconelli E; Tikkinen KAO; Trelle S; Zaid H; Røttingen JA; Swaminathan S
N Engl J Med; 2021 Feb; 384(6):497-511. PubMed ID: 33264556
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
Kim MS; An MH; Kim WJ; Hwang TH
PLoS Med; 2020 Dec; 17(12):e1003501. PubMed ID: 33378357
[TBL] [Abstract][Full Text] [Related]
17. Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020 : A Cross-Sectional Study.
Garg S; Patel K; Pham H; Whitaker M; O'Halloran A; Milucky J; Anglin O; Kirley PD; Reingold A; Kawasaki B; Herlihy R; Yousey-Hindes K; Maslar A; Anderson EJ; Openo KP; Weigel A; Teno K; Ryan PA; Monroe ML; Reeg L; Kim S; Como-Sabetti K; Bye E; Shrum Davis S; Eisenberg N; Muse A; Barney G; Bennett NM; Felsen CB; Billing L; Shiltz J; Sutton M; Abdullah N; Talbot HK; Schaffner W; Hill M; Chatelain R; Wortham J; Taylor C; Hall A; Fry AM; Kim L; Havers FP
Ann Intern Med; 2021 Oct; 174(10):1409-1419. PubMed ID: 34370517
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials.
Bokharee N; Khan YH; Khokhar A; Mallhi TH; Alotaibi NH; Rasheed M
Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1219-1244. PubMed ID: 33719819
[No Abstract] [Full Text] [Related]
19. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
[TBL] [Abstract][Full Text] [Related]
20. Real-life use of remdesivir in hospitalized patients with COVID-19.
Garcia-Vidal C; Meira F; Cózar-Llistó A; Dueñas G; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Cardozo C; Hernandez-Meneses M; Alonso-Navarro R; Rico V; Agüero D; Bodro M; Morata L; Jordan C; Lopera C; Ambrosioni J; Segui F; Grafia N; Castro P; García F; Mensa J; Martínez JA; Sanjuan G; Soriano A;
Rev Esp Quimioter; 2021 Apr; 34(2):136-140. PubMed ID: 33675220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
